RT Journal Article
ID 1241d77b25882ad8
A1 Nagpal, Kalpana
A1 Kumar, Pradeep 
A1 Mohan, Anand 
A1 Thakur, Sourav 
T1 Dendrimers for Therapeutic Delivery: Compositions, Characterizations, and Current Status
JF Critical Reviews™ in Therapeutic Drug Carrier Systems
JO CRT
YR 2019
FD 2019-08-15
VO 36
IS 4
SP 277
OP 304
K1 dendrimers
K1 drug delivery
K1 applications
K1 diagnostic applications
AB Dendrimers, commonly referred to as <i>arborols</i>, offer tremendous opportunities for drug delivery, diagnostics, and treatment applications. This may be attributed to the characteristic features of their three architectural components: core, branches, and terminal groups. These components provide vast flexibility to designers. They act as highly moldable platforms that can be modified to suit the needs of application designers. Effectively, the type, length, and molecular weight of the core, branches and terminal groups may be customized to achieve desired characteristics and satisfy the demands of numerous applications. These perfectly designed multifunctional structures are reviewed in the current paper, focusing on their complex archetypical design for interphase applications; novel drug delivery applications, especially oral, ocular, pulmonary, transdermal; targeted, and controlled-release; and diagnosis and treatment
of diseases like cancer, diabetes, and autoimmune disorders.

PB Begell House
LK https://www.dl.begellhouse.com/journals/3667c4ae6e8fd136,5e5d9520430df68a,1241d77b25882ad8.html